190 related articles for article (PubMed ID: 21995575)
1. Intrinsic modulation of lymphocyte function by stromal cell network: advance in therapeutic targeting of cancer.
Görgün G; Anderson KC
Immunotherapy; 2011 Oct; 3(10):1253-64. PubMed ID: 21995575
[TBL] [Abstract][Full Text] [Related]
2. Targeting the stroma by T cells to limit tumor growth.
Zhang B
Cancer Res; 2008 Dec; 68(23):9570-3. PubMed ID: 19047130
[TBL] [Abstract][Full Text] [Related]
3. Immunotherapy: target the stroma to hit the tumor.
Kammertoens T; Schüler T; Blankenstein T
Trends Mol Med; 2005 May; 11(5):225-31. PubMed ID: 15882610
[TBL] [Abstract][Full Text] [Related]
4. Tumor-stroma interactions directing phenotype and progression of epithelial skin tumor cells.
Mueller MM; Fusenig NE
Differentiation; 2002 Dec; 70(9-10):486-97. PubMed ID: 12492491
[TBL] [Abstract][Full Text] [Related]
5. Induction of CD4(+) and CD8(+) T-cell responses to the human stromal antigen, fibroblast activation protein: implication for cancer immunotherapy.
Fassnacht M; Lee J; Milazzo C; Boczkowski D; Su Z; Nair S; Gilboa E
Clin Cancer Res; 2005 Aug; 11(15):5566-71. PubMed ID: 16061874
[TBL] [Abstract][Full Text] [Related]
6. Molecular insights into prostate cancer progression: the missing link of tumor microenvironment.
Chung LW; Baseman A; Assikis V; Zhau HE
J Urol; 2005 Jan; 173(1):10-20. PubMed ID: 15592017
[TBL] [Abstract][Full Text] [Related]
7. Targeting stromal-cancer cell interactions with siRNAs.
Aharinejad S; Sioud M; Lucas T; Abraham D
Methods Mol Biol; 2009; 487():243-66. PubMed ID: 19301651
[TBL] [Abstract][Full Text] [Related]
8. Cellular therapy to control tumor progression.
Kapp M; Rasche L; Einsele H; Grigoleit GU
Curr Opin Hematol; 2009 Nov; 16(6):437-43. PubMed ID: 19587587
[TBL] [Abstract][Full Text] [Related]
9. Can Targeting Stroma Pave the Way to Enhanced Antitumor Immunity and Immunotherapy of Solid Tumors?
Puré E; Lo A
Cancer Immunol Res; 2016 Apr; 4(4):269-78. PubMed ID: 27036971
[TBL] [Abstract][Full Text] [Related]
10. Tumor-host interactions: a far-reaching relationship.
McAllister SS; Weinberg RA
J Clin Oncol; 2010 Sep; 28(26):4022-8. PubMed ID: 20644094
[TBL] [Abstract][Full Text] [Related]
11. Lymphoid stroma in the initiation and control of immune responses.
Mueller SN; Ahmed R
Immunol Rev; 2008 Aug; 224():284-94. PubMed ID: 18759934
[TBL] [Abstract][Full Text] [Related]
12. Prostate tumor-stroma interaction: molecular mechanisms and opportunities for therapeutic targeting.
Sung SY; Chung LW
Differentiation; 2002 Dec; 70(9-10):506-21. PubMed ID: 12492493
[TBL] [Abstract][Full Text] [Related]
13. [Immune response and cancer].
El Hage F; Abouzahr-Rifai S; Meslin F; Mami-Chouaib F; Chouaib S
Bull Cancer; 2008 Jan; 95(1):57-67. PubMed ID: 18230571
[TBL] [Abstract][Full Text] [Related]
14. The role of stroma in immune recognition and destruction of well-established solid tumors.
Yu P; Rowley DA; Fu YX; Schreiber H
Curr Opin Immunol; 2006 Apr; 18(2):226-31. PubMed ID: 16459066
[TBL] [Abstract][Full Text] [Related]
15. Multiple roles for CD4+ T cells in anti-tumor immune responses.
Kennedy R; Celis E
Immunol Rev; 2008 Apr; 222():129-44. PubMed ID: 18363998
[TBL] [Abstract][Full Text] [Related]
16. Constitutive up-regulation of integrin-mediated adhesion of tumor-infiltrating lymphocytes to osteoblasts and bone marrow-derived stromal cells.
Tanaka Y; Mine S; Hanagiri T; Hiraga T; Morimoto I; Figdor CG; van Kooyk Y; Ozawa H; Nakamura T; Yasumoto K; Eto S
Cancer Res; 1998 Sep; 58(18):4138-45. PubMed ID: 9751626
[TBL] [Abstract][Full Text] [Related]
17. Fibroblast and prostate tumor cell cross-talk: fibroblast differentiation, TGF-β, and extracellular matrix down-regulation.
Coulson-Thomas VJ; Gesteira TF; Coulson-Thomas YM; Vicente CM; Tersariol IL; Nader HB; Toma L
Exp Cell Res; 2010 Nov; 316(19):3207-26. PubMed ID: 20727350
[TBL] [Abstract][Full Text] [Related]
18. From cancer immunosurveillance to cancer immunotherapy.
Stagg J; Johnstone RW; Smyth MJ
Immunol Rev; 2007 Dec; 220():82-101. PubMed ID: 17979841
[TBL] [Abstract][Full Text] [Related]
19. T-cell adoptive therapy of tumors: mechanisms of improved therapeutic performance.
Cohen PA; Peng L; Kjaergaard J; Plautz GE; Finke JH; Koski GK; Czerniecki BJ; Shu S
Crit Rev Immunol; 2001; 21(1-3):215-48. PubMed ID: 11642606
[TBL] [Abstract][Full Text] [Related]
20. Differing phenotypes between intraepithelial and stromal lymphocytes in early-stage tongue cancer.
Katou F; Ohtani H; Watanabe Y; Nakayama T; Yoshie O; Hashimoto K
Cancer Res; 2007 Dec; 67(23):11195-201. PubMed ID: 18056444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]